GlassScriptPhysician profile
Richard A Howard
NPI 1447249255
$3,512.98
in general payments reported to CMS, 2019-2025
16 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,346 · 2021: $59.17 · 2022: $613 · 2023: $272 · 2024: $69.73 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,345.64 | 2019 | |
| Shockwave Medical, INC | $358.54 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $293.60 | 2021-2025 | Aveir, Gallant |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $232.55 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $55.68 | 2023-2025 | |
| Amgen INC. | $36.62 | 2022 | |
| Esperion Therapeutics, INC. | $24.75 | 2025 | Nexletol |
| Getinge USA Sales, LLC | $23.63 | 2023 | Sensation 7fr. 34cc Iab |
| Abiomed | $23.17 | 2021 | |
| Baxter Healthcare | $22.95 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Novo Nordisk INC | $18.97 | 2023 | Ozempic, Rybelsus |
| Heartflow, INC. | $18.91 | 2025 | |
| Pfizer INC. | $17.15 | 2022 | |
| Chiesi USA, INC. | $14.87 | 2022 | |
| Boston Scientific Corporation | $14.26 | 2023 | Watchman Flx |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.